U.S. Imposes Wide-Ranging Tariffs on Patented Drugs, Sets Carve-Outs and Incentives for Onshoring
The administration announced sweeping tariffs on patented pharmaceutical products and ingredients under Section 232 of the Trade Expansion Act of 1962. A 100% levy applies broadly, with phased implementation, country-specific lower rates, and exemptions for firms that sign pricing and onshoring agreements. Generics and biosimilars are currently exc…